Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Let it be: Preserving tumor-draining lymph nodes in the era of immuno-oncology

Cancer Cell(2024)10.1016/j.ccell.2024.05.015Source: DataRank Database

Let it be: Preserving tumor-draining lymph nodes in the era of immuno-oncology is a research paper published in Cancer Cell (2024). On theSindex it has a DataRank of 0. It has been cited 36 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

36 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)OA: closedTopics (7)IDs (PubMed)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (0/2)

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (3)

Shiruyeh Schokrpur ORCID,J. Silvio Gutkind ORCID,Robert Saddawi‐Konefka ORCID

Live enrichment

PubMed:38861928

NCI NIH HHS

Grant: R01 CA247551

NIDCR NIH HHS

Grant: U01 DE028227

Adamas Pharmaceuticals

NIH

closedLicense: http://www.elsevier.com/open-access/userlicense/1.0/

publisherhttps://api.elsevier.com/content/article/PII:S1535610824001831?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1535610824001831?httpAccept=text/plain

MeSH Terms

Lymph NodesAnimalsHumansNeoplasmsLymphatic MetastasisImmunotherapyLymph Node Excision

Let it be: Preserving tumor-draining lymph nodes in the era of immuno-oncology

FAIR Checklist

Authors (3)

Funding (4 grants)

Open Access

Topics